Genetic Testing for Longevity: What Tests to Get and How to Interpret Results

Consumer genetic testing has matured to the point where it's genuinely actionable for longevity planning, but the landscape is confusing and most people either over-interpret or under-utilize their results. Here's the practical breakdown. At the entry level, 23andMe (~$200) gives you genotyping on 640,000 SNPs — enough to check the major longevity-relevant variants but far from comprehensive. Nebula Genomics offers 30x whole genome sequencing ($300-400), which captures virtually all ~3 billion base pairs and is the better investment if you're serious. For clinical-grade results, companies like Dante Labs and Nebula offer 100x WGS with CLIA-certified reporting. The key distinction: genotyping chips test known variants at fixed positions, while WGS reads everything and can catch rare variants that chips miss entirely. If you're only going to test once, get WGS.

The longevity-relevant SNPs worth checking immediately: APOE (rs429358, rs7412) — the single most impactful genetic variant for healthspan. APOE e4/e4 carriers have ~12x Alzheimer's risk; e2/e3 is protective. This is actionable because e4 carriers benefit disproportionately from cardiovascular risk management, exercise, and possibly early monitoring. MTHFR (rs1801133, rs1801131) — C677T and A1298C variants reduce methylation efficiency by 30-70%, affecting homocysteine levels and B-vitamin metabolism. Actionable: switch from folic acid to methylfolate, supplement with methylcobalamin instead of cyanocobalamin. COMT (rs4680) — Val158Met affects dopamine and estrogen metabolism; Met/Met ('worrier') variants may benefit from different stress management and methylation support. FOXO3 (rs2802292) — the most replicated longevity-associated gene; G allele carriers show up in centenarian studies consistently. Less directly actionable but useful for risk stratification. Also check: PCSK9 (cholesterol), ACE (cardiovascular), CYP1A2 (caffeine metabolism), HFE (iron overload risk), and VDR (vitamin D receptor variants).

Once you have raw data, the interpretation layer matters enormously. Promethease ($12, promethease.com) cross-references your variants against SNPedia and produces a comprehensive report — overwhelming but thorough. Genetic Genie (free) focuses specifically on methylation and detox pathways, which is useful for supplement planning. Rhonda Patrick's FoundMyFitness Genetics tool ($25) is the most curated option — it focuses on variants where the evidence actually supports intervention and ignores the noise. SelfDecode offers AI-powered analysis but at a premium ($200+/year). The practical workflow: get WGS from Nebula, run the raw data through Promethease for the full picture, then use FoundMyFitness for the actionable subset.

Honest limitations: consumer genetic testing captures common variants well but misses structural variants, copy number variations, and most epigenetic modifications. Polygenic risk scores (combining thousands of small-effect variants) are improving but still explain only 5-15% of variance for most complex traits. A 'normal' genetic result doesn't mean low risk — it means your risk is closer to the population average, which for many diseases is still substantial. Gene-environment interactions are massive and poorly captured. And perhaps most importantly, genetics loads the gun but environment pulls the trigger — even strong genetic risk factors like APOE e4 are modifiable through lifestyle. The biggest mistake people make is treating genetic results as destiny rather than as information that should modify their behavioral and medical strategy.